Annual report pursuant to Section 13 and 15(d)

Income Taxes

v3.22.0.1
Income Taxes
12 Months Ended
Jan. 01, 2022
Income Taxes  
Income Taxes

Note 7 – Income Taxes

The components of loss before income taxes consist of the following:

 

Fiscal Year Ended

    

January 1, 2022

    

January 2, 2021

December 28, 2019

Domestic operations

$

(10,460)

$

(1,738)

$

(10,618)

Foreign operations

 

472

 

532

 

507

Total loss before income taxes

$

(9,988)

$

(1,206)

$

(10,111)

The income tax provision consists of the following:

 

Fiscal Year Ended

    

January 1, 2022

    

January 2, 2021

December 28, 2019

Current:

 

  

 

  

Federal tax

$

$

50

$

State tax

68

80

6

Foreign tax

 

283

177

 

144

Total current taxes

 

351

 

307

 

150

Deferred:

 

  

 

  

Federal tax

 

(6,628)

(453)

 

(1,311)

State tax

 

(407)

(225)

 

(417)

Total deferred taxes

 

(7,035)

 

(678)

 

(1,728)

Valuation allowance

 

7,035

 

678

 

23,015

Income tax provision

$

351

$

307

$

21,437

Income tax provision differs from the amount that would result from applying the federal statutory rate as follows:

    

January 1, 2022

    

January 2, 2021

December 28, 2019

Income tax at U.S. federal statutory rate

$

(2,098)

$

(253)

$

(2,123)

Tax attributes written off

 

50

 

Share-based compensation

 

(4,602)

(318)

 

729

State income tax, net of federal tax effect

 

(269)

(115)

 

(325)

Foreign tax

 

243

144

 

106

Other

 

42

121

 

35

Change in valuation allowance

 

7,035

678

 

23,015

Effective tax provision

$

351

307

$

21,437

For fiscal years 2021, 2020 and 2019, the effective tax rate for the Company was (3.5)%, (25.4)% and (212.0)%, respectively. The Company’s effective tax rate for fiscal years 2021, 2020 and 2019 differs from the U.S. federal rate primarily as a result of non-deductible share-based compensation, the write-off of expired state net operating loss carryforwards, and the change in the valuation allowance maintained against the Company’s deferred tax assets.

Deferred tax assets and deferred tax liabilities consisted of the following:

    

January 1, 2022

    

January 2, 2021

Deferred tax assets:

 

  

 

  

Inventory and inventory related allowance

$

1,373

$

1,082

Lease liabilities

10,830

7,311

Share-based compensation

 

3,108

 

2,102

Book over tax depreciation

468

Intangibles

 

161

 

660

Sales and bad debt allowances

 

1,021

 

1,044

Accrued compensation

 

445

 

436

Net operating loss

 

32,102

 

24,131

Other

 

210

 

186

Total deferred tax assets

 

49,250

 

37,420

Valuation allowance

 

(37,637)

 

(30,516)

Net deferred tax assets

 

11,613

 

6,904

Deferred tax liabilities:

 

  

 

  

Right-of-use assets

10,203

6,879

Tax over book depreciation

 

1,410

 

Other

 

 

25

Total deferred tax liabilities

 

11,613

 

6,904

Net deferred tax assets

$

$

As of January 1, 2022, federal and state net operating loss (“NOL”) carryforwards were $116,705 and $85,964, respectively. Federal NOL carryforwards of $1,295 were acquired in the acquisition of WAG which are subject to Internal Revenue Code section 382 and limited to an annual usage limitation of $135. Federal NOL carryforwards begin to expire in 2029, while state NOL carryforwards begin to expire in 2022. The state NOL carryforwards expire in the respective tax years as follows:

2022

    

$

975

2023

 

3,013

2024

 

2,368

2025

 

3,326

2026

 

2,982

Thereafter

 

73,300

$

85,964

Under the provisions of ASC 740, management is required to evaluate whether a valuation allowance should be established against its deferred tax assets based on the consideration of all available evidence using a “more likely than not” standard. Realization of deferred tax assets is dependent upon taxable income in prior carryback years, estimates of future taxable income, tax planning strategies, and reversal of existing taxable temporary differences. ASC 740 provides that forming a conclusion that a valuation allowance is not needed is difficult when there is negative evidence such as cumulative losses in recent years or losses expected in early future years. As of January 1, 2022, mainly due to cumulative losses in recent years, the Company maintained a valuation allowance in the amount of $37,637 against deferred tax assets that were not more likely than not of being realized.

We are subject to U.S. federal income tax as well as income tax of foreign and state tax jurisdictions. The tax years 2016-2021 remain open to examination by the major taxing jurisdictions to which the Company is subject, except the Internal Revenue Service for which the tax years 2017-2021 remain open. The Company does not anticipate a significant change to the amount of unrecognized tax benefits within the next twelve months.

Included in accrued expenses are income taxes payable of $145 and $119 as of January 1, 2022 and January 2, 2021, respectively, consisting primarily of current foreign taxes. Included in other non-current liabilities are income taxes payable of $803 and $702 as of January 1, 2022 and January 2, 2021, respectively, relating to accrued future foreign withholding taxes.